As tumors evolve, they often become heterogeneous, meaning they contain a diverse population of cells with varying genetic and phenotypic characteristics. Histologically, this heterogeneity can be observed as variations in cell size, shape, and staining patterns within the tumor. This tumor heterogeneity poses challenges for treatment, as different subpopulations of cells may respond differently to therapies.
